Diverse, large-scale health genomic resources are key to realizing the true potential of research, and to fully exploit the power of new health technologies based on artificial intelligence (AI), to improve health for all.
Diverse, large-scale health genomic resources are key to realizing the true potential of research, and to fully exploit the power of new health technologies based on artificial intelligence (AI), to improve health for all.
Chair of CGEn’s Scientific Advisory Board, Dr. Edward M. Rubin has been named a Fellow of the prestigious Royal Society of Canada (RSC) in recognition of his long-term contributions to advancing genomics internationally.
With this renewed support from the Government of Canada through the CFI, CGEn is poised to embark upon the next stage of its strategic vision, continuing to provide the leading genomic infrastructure for Canada’s research and innovation community.
Diverse, large-scale health genomic resources are key to realizing the true potential of research, and to fully exploit the power of new health technologies based on artificial intelligence (AI), to improve health for all.
April 25, 2022 – CGEn, Canada’s national platform for genome sequencing and analysis, and its partners are marking World DNA Day
CGEn is pleased to announce the appointment of Dr. Bartha Maria Knoppers as a member of our Board of Directors.
The Board of Directors and Executive Committee of CGEn, Canada’s national platform for genome sequencing and analysis, is pleased to
Every spcies on Earth possesses a characteristic genome, shaped by millions of years of evolution. Through the study of genomes—the
Over the last few months CGEn through its nodes in Toronto, Montreal and Vancouver have joined the fight against COVID-19
